Sobi to present new data at the ASH 2021 Annual Meeting : vi

/PRNewswire/ -- Sobi™ will present new data at the 63rd Annual Meeting of the American Society of Hematology (ASH) taking place from 11-14 December 2021....

Related Keywords

Norway , Georgia , United States , Australia , Japan , United Kingdom , Brazil , Liechtenstein , Canada , Russia , Iceland , New Zealand , Stockholm , Sweden , Kuwait , Saudi Arabia , Georgia World Congress Center , Switzerland , America , American , Hemophagocytic Lymphohistiocytosis , Ravi Rao , Elocta Eloctate , Prnewswire Sobi , European Commission , Sobi Investor Relations Team , Clinical Development Program , Meeting Of The American Society Hematology , Group Trial , Us Food Drug Administration , European Medicines Agency , Committee For Medicinal Products Human Use , Head Of Research Development , Annual Meeting , American Society , Chief Medical Officer , Delays Time , First Spontaneous Bleed Event , Previously Untreated Patients , Post Hoc Analysis , Session Time , Presentation Time , Alfa Half Life , Clearance Are Independent , Willebrand Factor , Severe Hemophilia , Observational Descriptive Study , Antihemophilic Factor , Pegcetacoplan Treatment , Paroxysmal Nocturnal Hemoglobinuria , Georgia Ballroom , Hemoglobin Measures Observed , Real World Evidence , Hoc Analysis , Baseline Hemoglobin Levels Greater Than , Long Term Safety , Paroxysmal Nocturnal Hemoglobinuria Patients , Hematologic Response , Platelet Response When Switching , Immune Thrombocytopenia , Thromboembolic Events , Platelet Count Occurring , Avatrombopag Immune Thrombocytopenia , Clinical Development , Observational Multicenter Study , Adult Patients , Double Blind Placebo Controlled , Parallel Group Trial , Open Label Extension Phase , Pediatric Patients , Primary Hemophagocytic Lymphohistiocytosis , World Treatment Patterns , Activation Syndrome , Systemic Juvenile Idiopathic Arthritis , Anti Interferon Gamma , Single Arm Study , Monoclonal Antibody , Macrophage Activation Syndrome , Drug Administration , Medicinal Products , Human Use , Orphan Drug Designation , North America , Middle East , Sobi Media , Cision Ab ,